Neurogastrx
Woburn
About Neurogastrx
Neurogastrx, Inc. is a venture-stage biopharmaceutical company developing products for the treatment of gastrointestinal disorders.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $105.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Aug 2021)
- Website: neurogastrx.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/neurogastrx-18420 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.